These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2991691)

  • 1. The methylenedioxyindene calcium antagonists.
    Rahwan RG
    Life Sci; 1985 Aug; 37(8):689-94. PubMed ID: 2991691
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclic AMP level, dissociation of membrane-bound calmodulin and regulation of calcium transport in the heart sarcoplasmatic reticulum in circulatory hypoxia].
    Antipenko AE; Sviderskaia EV; Lyzlova SN
    Vopr Med Khim; 1985; 31(4):70-3. PubMed ID: 2996224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of calmodulin in regulation of cardiac sarcoplasmic reticulum phosphorylation.
    Kranias EG; Bilezikjian LM; Potter JD; Piascik MT; Schwartz A
    Ann N Y Acad Sci; 1980; 356():279-91. PubMed ID: 6263150
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.
    Epstein PM; Fiss K; Hachisu R; Andrenyak DM
    Biochem Biophys Res Commun; 1982 Apr; 105(3):1142-9. PubMed ID: 6284165
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel mechanisms involved in superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum linked to cyclic ADP-ribose stimulation.
    Kumasaka S; Shoji H; Okabe E
    Antioxid Redox Signal; 1999; 1(1):55-69. PubMed ID: 11225733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS; Rhoads AR
    Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4.
    Brown DM; Hutchison L; Donaldson K; MacKenzie SJ; Dick CA; Stone V
    Toxicol Lett; 2007 Jan; 168(1):1-6. PubMed ID: 17129690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase.
    Norman JA; Ansell J; Phillips MA
    Eur J Pharmacol; 1983 Sep; 93(1-2):107-12. PubMed ID: 6313398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular localization of the calcium antagonist propyl-methylenedioxyindene in cardiac tissue.
    Lynch JJ; Rahwan RG; Witiak DT; Cazer FD
    Gen Pharmacol; 1983; 14(6):571-8. PubMed ID: 6662339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K; Matsuda Y; Kase H; Yamada K
    Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
    [No Abstract]   [Full Text] [Related]  

  • 13. Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate dependent and calcium--calmodulin-dependent phosphorylations.
    Le Peuch CJ; Haiech J; Demaille JG
    Biochemistry; 1979 Nov; 18(23):5150-7. PubMed ID: 227448
    [No Abstract]   [Full Text] [Related]  

  • 14. Relaxing and inotropic effects of cyclic AMP on skinned cardiac cells.
    Fabiato A; Fabiato F
    Nature; 1975 Feb; 253(5492):556-8. PubMed ID: 163977
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for an endogenous protein inhibitor of sarcoplasmic reticulum calcium pump in heart muscle.
    Narayanan N; Lee P; Newland M; Khandelwal RL
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1158-64. PubMed ID: 6817750
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium inhibition of a heat-stable cyclic nucleotide phosphodiesterase from Neurospora crassa.
    Shaw NM; Harding RW
    FEBS Lett; 1983 Feb; 152(2):295-9. PubMed ID: 6298002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions with calmodulin: potential mechanism for some inhibitory actions of tetracyclines and calcium channel blockers.
    Schlondorff D; Satriano J
    Biochem Pharmacol; 1985 Sep; 34(18):3391-3. PubMed ID: 2994682
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
    Reynolds CH; Claxton PT
    Biochem Pharmacol; 1982 Feb; 31(3):419-21. PubMed ID: 6280730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
    Movsesian MA; Ambudkar IS; Adelstein RS; Shamoo AE
    Biochem Pharmacol; 1985 Jan; 34(2):195-201. PubMed ID: 3155615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Calcium antagonists" and "calcium agonists": is there a place in pharmacology for these two misnomers?
    Weishaar RE
    Life Sci; 1984 Jul; 35(5):455-62. PubMed ID: 6748857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.